Albuterol/salbutamol

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaChronic Obstructive Pulmonary DiseaseSeasonal Allergic RhinitisAllergic AsthmaConjunctivitis

1050 competitors in Asthma

#DrugCompanyPhaseTrials

1

Albuterol/salbutamol

GSK

Approved

152

Veramyst

GSK

Preclinical

463

Xolair

Roche

Preclinical

254

Cinqair

Teva

Preclinical

135

Asmanex

Novartis

Preclinical

56

Celexa

AbbVie

Preclinical

17

Spiriva

Boehringer Ingelheim

Preclinical

88

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

89

Formoterol Fumarate

AstraZeneca

Preclinical

810

Symbicort

AstraZeneca

Preclinical

6Show 15 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma15 trials

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

Completed·Sanofi·Phase 3·NCT02528214·210 enrolled

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

Completed·GSK·Phase 4·NCT02654145·145 enrolled

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Completed·Sanofi·Phase 3·NCT02414854·1,902 enrolled

Show 12 more trials

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

Withdrawn·GSK·Phase 3·NCT03376932

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Completed·Teva·Phase 3·NCT02031640·1,113 enrolled

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Completed·GSK·Phase 3·NCT01431950·238 enrolled

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Completed·Teva·Phase 3·NCT02040779·273 enrolled

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma

Completed·GSK·Phase 3·NCT02483975·111 enrolled

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

Completed·GSK·Phase 3·NCT02924688·2,436 enrolled

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Completed·Teva·Phase 3·NCT02139644·787 enrolled

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Completed·Teva·Phase 2·NCT01479621·909 enrolled

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Completed·Teva·Phase 3·NCT02513160·713 enrolled

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

Completed·Teva·Phase 3·NCT02040766·628 enrolled

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Completed·Teva·Phase 2·NCT01576718·889 enrolled

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

Completed·GSK·Phase 2·NCT03012061·425 enrolled

Chronic Obstructive Pulmonary Disease8 trials

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 3·NCT02345161·1,811 enrolled

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 3·NCT02729051·1,055 enrolled

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 4·NCT03474081·800 enrolled

Show 5 more trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 4·NCT02257372·236 enrolled

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 4·NCT02275052·198 enrolled

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Withdrawn·GSK·Phase 3·NCT02731846

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 4·NCT03478683·729 enrolled

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed·GSK·Phase 4·NCT03478696·732 enrolled

Conjunctivitis1 trial

Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

Completed·Merck & Co.·Phase 3·NCT02478398·1,025 enrolled

MPA1 trial

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Completed·GSK·Phase 3·NCT02257385·967 enrolled

Seasonal Allergic Rhinitis1 trial

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Completed·OOrganon and Co·Phase 4·NCT00070707·188 enrolled

3 more indications

Efficacy1 trial

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Completed·GSK·Phase 4·NCT02799784·236 enrolled

Allergic Asthma1 trial

A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

Withdrawn·GSK·Phase 2·NCT03707678

Function1 trial

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Completed·GSK·Phase 4·NCT01691482·56 enrolled

Details

Drug Info

Related News